Case report: Identification of a novel heterozygous germline ERCC2 mutation in a patient with dermatofibrosarcoma

Qing Zhang1, Yongzhi Ju2,3,4, Xia You2,3,4

  • 1Department of Orthopaedic Oncology, Beijing Ji Shui Tan Hospital, Peking University, Beijing, China.

Frontiers in Oncology
|August 29, 2022
PubMed

Insights

A novel germline ERCC2 mutation was identified in a patient with dermatofibrosarcoma protuberans (DFSP). This finding expands the understanding of DFSP genetic mutations and potential therapeutic targets.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Dermatofibrosarcoma protuberans (DFSP) is a rare soft tissue sarcoma with a high local recurrence rate after surgical resection.
  • The genetic basis of DFSP, beyond known chromosomal translocations, remains largely unexplored, particularly the role of DNA repair gene mutations.

Related Concept Videos